Yexiang Sun

Dr. Yexiang Sun


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
YYYue-Qi Yin
Yue-Qi Yin
YLYu-Hui Liu
Yu-Hui Liu
JZJing Zhu
Jing Zhu
PSPeng Shen
Peng Shen
YCYun-Peng Chen
Yun-Peng Chen
YSYexiang Sun
Yexiang Sun
Introduction: Understanding molecular transmission patterns is critical for HIV prevention designed with key populations. This study aimed to characterize the molecular epidemiology, transmission networks, and underlying factors associated with HIV-1 transmission in Ningbo during 2018–2022. Methods: We analyzed data from 1,409 newly diagnosed people living with HIV who had successful genotyping. A maximum likelihood phylogenetic tree was constructed, and transmission clusters were identified using 1.3% distance and 0.9 bootstrap values. Multivariate logistic regression was applied to identify factors associated with clustered, large clusters (≥10 nodes) and fast-growing clusters. Results: Molecular analysis revealed 11 distinct HIV-1 subtypes and some unique recombinant forms (URFs), with CRF07_BC (41.6%) and CRF01_AE (33.2%) as the most prevalent. CRF07_BC consistently tended to form larger, more densely connected clusters, whereas CRF01_AE networks primarily exhibited sparse, fragmented distributions. Molecular transmission network analysis identified 9 large clusters and 12 fast-growing clusters. HIV-1 subtypes were associated with the large clusters and fast-growing clusters. CRF07_BC formed larger clusters (aOR = 7.80, 95%CI: 4.70–13.49) and fast-growing clusters (aOR = 6.02, 95%CI: 3.80–9.78) compared to CRF01_AE. Temporally, the molecular transmission networks (MTNs) expanded rapidly in 2020–2021. Conclusion: This study elucidates the MTNs of HIV-1 in Ningbo, highlighting the role of subtype diversity and demographic traits in shaping transmission networks. Continuous monitoring of HIV-1 molecular subtypes among key populations may serve as feasible and focused prevention strategies to curb HIV transmission.

24 August 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
YYYueqi Yin
Yueqi Yin
ZYZongming Yang
Zongming Yang
PSPeng Shen
Peng Shen
HDHongjun Dong
Hongjun Dong
Yun-Peng ChenYun-Peng Chen
Yun-Peng Chen
YSYexiang Sun
Yexiang Sun
Background China has historically been a high-prevalence area for hepatitis B virus (HBV) infection, leading to a high incidence of adverse liver diseases and significant disease burden. However, comprehensive data on HBV infection and associated adverse liver diseases in the Chinese population remain limited. This study aimed to analyse the risk factors for adverse liver outcomes in patients who tested positive for hepatitis B surface antigen (HBsAg). Method A matched retrospective cohort study was conducted from 1 January to 30 September 2013 in Jiangshan and Shiqi towns in Yinzhou District, Ningbo, Zhejiang Province. Data were sourced from the Yinzhou Health Information System. HBsAg-positive patients were matched 1:2 by birth year, sex, town and calendar period with HBsAg-negative controls. Adverse liver diseases, including cirrhosis, liver cancer and liver failure, were identified as outcomes, with follow-up continuing until 31 December 2022. Cox proportional hazards models were used to assess the associations between HBV infection and the risks of adverse liver disease and all-cause mortality, adjusting for age, sex, education, location, tobacco use, alcohol consumption and physical activity. Results A total of 1, 454 HBsAg-positive patients and 2, 766 matched controls were included, with 29, 945 person-years of follow-up (median: 9.17 years). During follow-up, 99 participants developed adverse liver diseases and 73 died. Among HBsAg-positive individuals, the incidence rate of adverse liver disease was 8.21 (95% CI: 6.59 to 10.12) per 1000 person-years, with a 12.24-fold higher risk than HBsAg-negative individuals (95% CI: 6.74 to 22.21). The mortality rate was 3.91 (95% CI: 2.84 to 5.25) per 1, 000 person-years in HBsAg-positive patients, with a 2.28-fold higher risk of all-cause mortality compared with the HBsAg-negative group (95% CI: 1.35 to 3.85). Elevated alanine aminotransferase (ALT) levels were associated with higher risks of adverse liver disease (Model 1 HR: 2.48, 95% CI: 1.49 to 4.12; Model 2 HR: 2.46, 95% CI: 1.48 to 4.12) and all-cause mortality (Model 1 HR: 3.14, 95% CI: 1.50 to 6.60; Model 2 HR: 2.77, 95% CI: 1.29 to 5.92). Conclusion This study established a population-based cohort in eastern China using a big data platform for longitudinal follow-up. Our findings indicate that HBsAg-positive individuals face an increased risk of adverse liver outcomes and all-cause mortality, with elevated ALT serving as a significant risk marker. Enhanced HBV screening among the general population and increased ALT monitoring frequency in HBsAg-positive individuals are recommended.